Market Cap | ₹41Cr |
ROE | 90.88% |
P/E Ratio(TTM) | -1.83 |
EPS(TTM) | -2.68 |
P/B Ratio | 0.00 |
Dividend Yield | 0.00% |
Industry P/E | 35.07 |
Book Value | -8.82 |
Debt to Equity | -10.70 |
Face Value | 2 |
Parent Organisation | Vivimed Labs Limited |
Managing Director | Mr. Santosh Varalwar |
BSE Symbol | 532660 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 102.92 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.00 | ||
Emcure Pharmaceuticals | NA (0.00%) | 33.72 | ||
Wockhardt | NA (0.00%) | -151.40 |